Welcome to our dedicated page for Park Dental Partners SEC filings (Ticker: PARK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Park Dental Partners's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Park Dental Partners's regulatory disclosures and financial reporting.
Park Dental Partners, Inc. reported modest top-line growth but sharply lower GAAP profitability for the quarter and year-to-date ended June 30, 2026. Revenue rose to $66.2 million for the quarter and $128.9 million for six months, up 5.1% and 5.6% year over year, driven by higher clinical hours, acquisitions and improved reimbursement rates. Same practice revenue increased 2.3% for the quarter and 3.2% year-to-date, with patient visits and patient retention essentially flat to slightly positive.
GAAP net income fell to $1.3 million for the quarter (down 47.5%) and $1.0 million year-to-date (down 76.8%) as share-based compensation of $7.1 million and higher operating costs compressed margins; diluted EPS declined to $0.22 for the quarter and $0.16 for six months. Adjusted EBITDA was relatively stable at $7.4 million for the quarter and $12.2 million year-to-date, but margins narrowed. The company maintained a solid cash balance of $24.4 million, total assets of $186.3 million, and shareholders’ equity of $29.8 million, while carrying $11.0 million of long-term debt, $69.2 million of deferred compensation and significant lease obligations. It agreed to acquire Village Family Dental DSO in 2026 for approximately $29.9 million in cash, 474,535 restricted shares valued at $9.2 million, and up to $6.9 million in contingent consideration.
Park Dental Partners reported second-quarter 2026 revenue of $66.2 million, up 5.1% from $63.0 million in 2025, with same practice revenue growth of 2.3%. Patient visits were 185,569 and the affiliated doctor base increased to 219 from 203.
Profitability weakened. Gross margin fell to $9.5 million from $11.9 million, with gross margin percentage declining to 14.4% from 18.9%. Net income for the quarter decreased to $1.3 million, down 47.5% from $2.6 million, and diluted EPS declined to $0.22 from $1.45. Adjusted EBITDA was $7.4 million, slightly below $7.6 million a year earlier.
For full-year 2026, the company now expects revenue of $256.0–$260.0 million versus $244.5 million in 2025 and Adjusted EBITDA of $21.0–$23.0 million versus $22.0 million, implying an Adjusted EBITDA margin of 8.2%–8.8% compared with 9.0%. The outlook includes 3.5%–5.0% organic revenue growth and approximately $2 million of recurring public company costs.
Park Dental Partners, Inc. agreed to acquire the dental services organization supporting Village Family Dental in North Carolina and to affiliate with its professional practices through a management-services structure. At closing, Park Dental will obtain all economic, voting and governance interests in the DSO, while clinical decisions remain with licensed dentists.
The Transaction Agreement provides for base consideration of $39.1 million, including 474,535 restricted shares of common stock valued at $9.2 million as rollover equity, with the balance in cash subject to customary adjustments. The seller may earn up to $4.6 million of EBITDA-based contingent consideration and up to $2.3 million of employment-contingent consideration, for potential aggregate consideration ranging from $39.1 million to $46.0 million.
The deal would add 12 practice locations and 48 doctors in North Carolina and mark Park Dental’s entry into its fourth state. The Village Family Dental DSO will operate as a subsidiary providing management support, while practices are expected to retain the Village Family Dental name. Closing is expected in 2026, subject to customary approvals and conditions, and there is no assurance the transaction will be completed.
SMITH PHILIP IRVING reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. director Philip Irving Smith received a grant of 2,632 restricted stock units as equity compensation. Each unit represents one share of common stock and was granted for no cash consideration. The units vest in full on the first anniversary of the grant date, contingent on his continued board service, giving him 2,632 RSUs outstanding after this award.
SWENSON PETER G reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. CEO and Chairman Peter G. Swenson received a grant of 23,785 restricted stock units as equity compensation. Each unit represents a right to receive one share of common stock upon vesting and was granted for no cash consideration.
The restricted stock units vest in four equal installments of 25% on each of the first four anniversaries of the grant date, contingent on Swenson’s continued service and the terms of the award agreement. Following this grant, he holds 23,785 restricted stock units directly.
Steele Christopher Eugene reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director and officer Christopher Eugene Steele received a grant of 5,855 restricted stock units. Each unit represents the right to receive one share of common stock if and when it vests.
The award vests in four equal installments of 25% on each of the first four anniversaries of the grant date, so long as Steele continues to provide service and satisfies the award terms. The units were granted for no cash consideration, reflecting routine equity-based compensation rather than an open-market share purchase or sale.
Smith Christopher Charles reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director Christopher Charles Smith received a grant of 2,632 restricted stock units. Each unit represents one share of common stock, granted for no cash consideration. The award vests in full on the first anniversary of the grant date, contingent on his continued board service.
Bernander Christopher James reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that Chief Financial Officer Christopher James Bernander received a grant of 11,184 restricted stock units. Each unit represents a contingent right to receive one share of Park Dental Partners common stock upon vesting.
The restricted stock units vest in four equal 25% installments on each of the first four anniversaries of the grant date, conditioned on his continued service and the terms of the award agreement. The units were granted for no cash consideration, and following this award Bernander holds 11,184 restricted stock units directly.
Schaefer Anna Marie reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director Anna Marie Schaefer received a grant of 2,632 restricted stock units (RSUs). Each RSU represents one share of common stock upon vesting. The RSUs vest in full on the first anniversary of the grant date, and were granted for no cash consideration.
Law Alan Siems reported acquisition or exercise transactions in this Form 4 filing.
Park Dental Partners, Inc. reported that director and officer Alan Siems received a grant of 7,796 restricted stock units. Each unit represents a contingent right to receive one share of common stock upon vesting. The award was granted for no cash consideration.
The restricted stock units vest in four equal installments of 25% on each of the first four anniversaries of the grant date, conditioned on Mr. Siems’ continued service and the terms of the applicable award agreement. Following this grant, he holds 7,796 restricted stock units directly.